from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1172c/PE12

LFCtreatmentdescriptionclass of inhibitor

-0.778

Amikacinug/mL Amikacintranslation

0.004

Cap5-10ug/mL Capreomycintranslation

0.476

Rox10-50 ug/mL Roxithromycintranslation

1.027

SM2-5 ug/mL Streptomycintranslation

-0.822

Tet5-10 ug/mL Tetracyclinetranslation

-0.626

Rif0.2-5ug/mL Rifampicintranscription

-0.420

Rifp0.1-0.5ug/mL Rifapentinetranscription

2.963

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.609

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.705

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.324

Clofazimine10-13 ug/mL Clofaziminerespiration

0.047

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.646

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.534

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.971

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.180

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.804

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.544

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.158

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.050

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.488

KCN5-20 ug/mL Potassium cyaniderespiration

-0.466

NaN30.2-2 mM Sodium aziderespiration

0.749

Nigericin50 uM Nigericinrespiration

-1.193

TRC10-150 ug/mL Triclosanrespiration

-1.637

TRZ10-25 ug/mL Thioridazinerespiration

1.611

Valinomycin0.5-10 uM Valinomycinrespiration

0.897

ZnSO42 mM ZnSO4respiration

-0.869

menadione6-10 ug/mL Menadionerespiration

0.014

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.628

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.306

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.880

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.623

NRP_1Non-replicating persistence stage 1dosRassociated

0.840

Amp0.2mg/mL AmpicillincellWall

0.175

Cephalexin20-100 ug/mL CephalexincellWall

0.919

Cerulenin0.32-5 ug/mL CerulenincellWall

0.744

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.353

EMB10-20 ug/mL EthambutolcellWall

-0.168

Eta12-40 ug/mL EthionamidecellWall

-0.207

INH0.2-0.4 ug/mL IsoniazidcellWall

0.109

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.996

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.234

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.020

BZA0.12 mg/mL BenzamidearomaticAmides

0.061

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.191

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.028

H2O24 mM hydrogen peroxideDNAdamaging

0.403

Levo10 ug/mL LevofloxacinDNAdamaging

0.846

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.648

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.102

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.881

UVUV-irradiationDNAdamaging

-1.217

ARP41-4 ug/mL Antitubercular compound ARP4?

0.515

Antimycin12.5-50 ug/mL Antimycin A?

0.611

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.256

PA_110-50 ug/mL Antitubercular compound PA-1?

0.483

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.766

PA8240.2-2 ug/mL PA-824?

-0.685

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.286

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

1.018

Verapamil50 uM Verapamil?

0.212

mercaptoethanol2 mM 2-Mercaptoethanol?

1.244

methoxatin10-20 ug/mL Methoxatin?